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The time-dependent  increase  in the average affinity of serum antibody after immuniza- 
tion  (1),  is said to be a  result of antigen-driven  selection of those antibody-forming cell 
precursors having the highest affinity antigen receptors (2). This interpretation infers that 
the  specificity  and  affinity  of  antigen-binding  receptors  on  antibody-forming  cell 
precursors are directly correlated to the serum antibody produced by progeny antibody- 
secreting cells. 
It  has  been  found  that  changes  in  the  affinity  of serum  antibody  with  time  after 
immunization reflect changes in the population of antibody-secreting cells. By determin- 
ing the concentration of antigen required to inhibit individual plaque-forming cells (PFC) 
assayed  at  various  times  after  immunization,  a  time-dependent  avidity increase  at  the 
antibody-secreting cell level is seen and is comparable to the increase in affinity found in 
serum  antibody  (3).  Thus,  a  good correlation  between  the  (intrinsic)  affinity of serum 
antibody and the avidity of the antibody-secreting cell products has been established. 
In contradistinction,  evidence correlating the avidity of antigen receptors on antibody- 
secreting  cell  precursors,  with  the avidity of antibody secreted  by their progeny cells,  is 
meager. Indirect evidence has been reported demonstrating that memory cells with high 
avidity antigen-binding receptors are required to give rise to high avidity antibody-secret- 
ing cells (4). However, the putatively high avidity precursors were not isolated and tested 
directly in these experiments. 
To directly determine  the  relationship  between the  avidity of secreted  antibody 
and  the  avidity  of antigen  receptors  on  precursors  of antibody-secreting  cells 
requires  the  isolation  of  precursor  cells  with  different  antigen  avidities  and 
measurement  of  the  avidities  of  antibody-secreting  cells  derived  from  these 
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precursors on antigen stimulation.  We have already directly demonstrated that 
populations  of  antigen-binding  cells  from  immune  (5)  and  nonimmune  (6) 
animals  contain  the  precursors  of antibody-secreting cells.  Others have found 
direct evidence that antigen-binding cells isolated from both nonimmune mice 
on  affinity  columns  (7)  and  from  immune  mice  on  antigen-derivatized  nylon 
fibers (8)  contain  antigen-specific precursors required to give adoptive primary 
and  secondary  immune  responses,  respectively. To  date,  neither  of the  latter 
methods  have  provided  adequate  purity  of  precursor  activity  or  enabled 
purification of precursors with a  known range of antigen-binding avidities, both 
of which are required for a  precursor-product correlation study. 
The  development  of  a  fluorescence-activated  cell  sorter  (FACS)  (9)  has 
enabled the isolation of virtually pure populations of viable antigen-binding cells 
with full functional activity (5, 6). We have isolated cells with low, medium, and 
high binding avidity for DNP by staining normal spleen cells with fluorescein- 
ated DNP-mouse gamma globulin (~DNP-MGG) and separation using a FACS. 
It has been postulated that precursors of low affinity antibody-secreting cells 
require  higher  concentrations  of antigen  to  bind  and  be  stimulated  than  do 
precursors  of high  affinity antibody-secreting cells  {1). Therefore, high  avidity 
cells  were  stained  using  low  concentrations  of  FDNP-MGG  while  low  and 
medium avidity cells were stained using moderately high concentrations in the 
presence  of various  concentrations  of the  univalent  competing  ligand  e-DNP- 
lysine (10,  11). 
The  precursor  activity  of  the  purified  DNP-binding  cells  was  tested  by 
transferring these  cells together with DNP-keyhole limpet  hemocyanin  (KLH) 
and  a  source of KLH carrier-primed cooperator cells into irradiated recipients 
and  subsequently  assaying  the  recipient spleens for anti-DNP-plaque-forming 
cells  (PFC).  In  addition  to  quantitating  the  precursor activity of the  purified 
DNP-binding cells, the hemolytic plaque assay was used to study the avidity of 
single antibody-secreting cells (3). By determining the avidity of anti-DNP-PFC 
resulting from the transfer of purified DNP-binding  cells with varying avidities 
for ~DNP-MGG,  we  have found a  direct correlation between the  avidity of the 
DNP  antigen-binding  cells  and  the  anti-DNP  antibody  secreted  by  the  PFC 
derived from them. 
Materials  and  Methods 
Animals.  Male and female mice of the congenic strains BALB/cN and BAB/14 Hz were used at 
the age of 2-6 mo (BAB/13 were kindly supplied by Dr. M. Potter (NCI, NIH} and BAB/14 were de- 
rived in this laboratory by one further back-cross to BALB/cN and subsequent repeated inbreeding of 
the resulting heterozygotes). 
Preparation o/Cell Suspensions  and Media.  Single  cell suspensions of spleen were prepared as 
previously described (5). Cell suspensions in preparation for loading onto nylon wool columns, cell 
separation, and immunofluorescent staining were prepared in Dulbecco's phosphate-buffered saline 
(PBS), pH 7.5, (12} supplemented with 5% heat-inactivated fetal calf serum (FCS}. Before processing 
spleen cell suspensions through the FACS, erythrocytes were lysed by incubating the cells for 5 min at 
0°C  in  Gey's balanced  salt  solution  (13) in  which the  NaC1 was  replaced  with  an  equimolar 
concentration of NH4C1. Spleen cells in preparation for plaquing were prepared in MEM with Hanks' 
balanced salt solution (14). FCS wherever used was first inactivated at 56°C for 30 min. 
Preparation of Carrier-Primed Splenic  T Cells, Indirect  Immunofluorescence  Staining for T and 
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Preparation  of  ~DNP-MGG  and  Staining  of  DNP-Binding  Cells.  MGG  was  purified  from 
BALB/cN  normal  serum  by  ion-exchange chromatography and  conjugated  with  l-fluoro-2-dini- 
trobenzene (Sigma Chemical Co.,  St. Louis, Mo.) at pH 8.0  in 0.5  M  NaHCO3 for 2-3 h  at room 
temperature. The resulting DNP-MGG contained an average of 23 DNP groups/molecule of MGG. 2 
Fluorescein  conjugates  of DNP-MGG  were  prepared  using  fluorescein  isothiocyanate (16).  The 
FDNP-MGG was fractionated by a  gradient elution from DEAE-cellulose (17, 18). Fractions with 
fluorescein per protein (F/P) ratios between 2 and 5 were pooled and concentrated by ultrafiltration. 
~DNP-MGG with an F/P ratio of 3.5 was used throughout these experiments. 
Staining  concentrations of  ~DNP-MGG  were  varied  from  6  to  1,600 ttg/ml,  0.1  ml  of  the 
appropriate ~DNP-MGG concentration was added/2  ×  107  pelleted cells. Subsequent to a  20  min 
incubation at 22-25°C the cells were pelleted through neat FCS and then washed once in an excess of 
medium. 
A  modification of the  above  staining procedure was used to  determine the relative avidity of 
~DNP-MGG-binding cells. A 10- to 100-fold molar excess of e-DNP-lysine (relative to the molarity of 
DNP present on the ~DNP-MGG) was included in the staining mixture. The proportion of binding 
cells observed by fluorescent microscopy in the presence and absence of e-DNP-lysine was determined 
and the percent inhibition of staining calculated. 
To demonstrate specificity  of inhibition, cells were simultaneously stained with ~DNP-MGG in the 
presence of various hapten concentrations and with an unrelated antigen, contrastingly fluorescent 
rhodamine-conjugated KLH  (RKLH)  (using 0.1  ml  of  RKLH  at  0.5  mg/ml/2  ×  107  cells).  The 
proportion of ~KLH-binding cells observed was unaffected by any of the e-DNP-lysine concentrations 
used. 
Purification  of FDNP-MGG-Binding Cells by the FA CS.  The FACS used here allows separation 
of cells according to fluorescence, light-scattering characteristics, or selected combinations of these 
two parameters. Details of separation protocol and efficiency have been previously described (5, 6). A 
typical separation yields two fractions of cells, an  enriched fraction containing greater than 85% 
FDNP-MGG-binding cells and  a  depleted fraction containing 500-fold  fewer FDNP-MGG-binding 
cells compared to the unseparated spleen. 
Antigens.  DNP-KLH  was prepared by reacting l-fluoro-2,4-dinitrobenzene (Sigma Chemical 
Co.) at pH 8.0, in 0.5 M NaHCO3 with KLH (Pacific Bio-Marine Supply Co., Venice, Calif.) for 2-3 h 
at room temperature. Molar ratios of DNP/105 daltons of KLH were calculated  3 and DNPs_lo-KLH 
was used  in these experiments. Aliquots of DNP-KLH  (prepared as described above) were alum 
precipitated at pH 6.5 with a 9% solution of ALK(SO,)~ for 3 h at room temperature. 
Irradiation  and Adoptive  Transfers.  Recipients in  adoptive transfer experiments received 600 
rads  whole-body X  irradiation,  16-18  h  before receiving cells.  A  modification of the  Mitchison 
hapten-carrier transfer  protocol  (19, 20)  was  used.  Various  combinations of normal  spleen cells, 
purified ~DNP-MGG-binding cells, spleen cells depleted of ~DNP-MGG-binding cells and KLH- 
primed splenic T cells were injected intravenously. 100 ttg of alum-precipitated DNP-KLH was given 
intraperitoneally immediately after injection of cells and  10  ttg of aqueous DNP-KLH was given 
intravenously on day 5. Recipients were bled and sacrificed on day 12, serum and cell suspensions of 
recipient spleens were assayed for anti-KLH antibody and DNP-PFC, respectively. 
DNP-PFC Assay  and  Inhibition  with  ~-DNP-Lysine  for  Determination  of  Relative  Hapten 
Avidities.  Anti-DNP antibody-secreting cells (PFC) were measured using a modified version of the 
hemolytic plaque technique (2t). SRBC were conjugated with 2,4,6-trinitrobenzene-sulphonic  acid 
(Eastman Organic Chemicals Div., Eastman Kodak Co., N. Y.)  (22). Virtually no PFC were observed 
using unconjugated SRBC. Fresh frozen guinea pig serum at a final concentration of 1/24 was used as 
a  complement source. In early experiments a  polyvalent rabbit antimouse antiserum was used to 
facilitate  hemolysis.  Since  substantial  numbers of indirect PFC  were not  found,  in  subsequent 
experiments only direct PFC were measured. We have detected identical numbers of DNP-PFC in 
experiments where the same spleens were assayed using either TNP-SRBC (22) or DNP-SRBC (23) as 
indicators. Due to the ease of preparation, TNP-SRBC were used in subsequent experiments. 
The plaque inhibition method of Andersson (3) was used to determine the relative avidity for DNP 
of the PFC. The term "avidity" rather than "affinity" is used here since it is not clear how accurately 
2  Based on E~ ~m -- 14 at 280 nm and ~M  --  1.74 × 10' at 360 nm for MGG and DNP, respectively. 
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an  affinity  constant  (Ka)  (24) can  be  determined  in  this  way.  Concentrations of  e-DNP-lysine 
ranging from 10 -4 to  10 -7 M  were included in some plaquing chambers. High avidity antibody is 
saturated  at  lower  concentrations of  e-DNP-lysine than  low  avidity  antibody.  Therefore,  low 
concentrations of e-DNP-lysine prevent high avidity  antibody from  lysing TNP-SRBC,  whereas 
higher concentrations of ~-DNP-lysine would be required to block hemolysis by low avidity antibody. 
Strictly,  a  weighted  product  of antibody  avidity  and  amount  secreted per  cell  is  measured  by 
e-DNP-lysine inhibition. However, since the sizes of uninhibited PFC varied less than about 50% in 
diameter, while the inhibitions vary over a 108 concentration range of inhibitor, the major parameter 
measured is relative avidity rather than amount per cell. In some experiments for assaying very low 
avidity DNP-PFC, multivalent DNP (DNP-MGG) was used as an inhibitor and was varied from 10 -5 
to 10 -s M DNP in the plaquing chambers. Inhibition of PFC with either e-DNP-lysine or DNP-MGG 
was specific for DNP-PFC and did not reduce the number of SRBC-PFC detected on day 4 of a 
primary response to 4  x  108 SRBC. 
Titrations.  Anti-KLH serum titers were individually determined using the passive microhemag- 
glutination technique (25).  KLH was coupled to SRBC using a  modification of the glutaraldehyde 
method (26).  Sera were heat inactivated at 56°C for 30 min before titration. 
Results 
Adoptive  Primary  Response  to  DNP-KLH.  The  DNP  precursor  activity 
contained in unprimed spleen was  determined using an  adoptive syngeneic or 
congenic  hapten-carrier  transfer  system  (19).  Graded  numbers  of  unprimed 
spleen cells and KLH-primed, nylon column-purified (15) T cells were mixed and 
transferred into irradiated recipients with antigen (see Materials and Methods). 
The  DNP-PFC  response of irradiated  recipients  reconstituted with  normal 
histocompatible spleen cells is substantially improved by supplementation with 
carrier-primed  cooperator cells  (27).  Fig.  1  a  shows  the  DNP-PFC  response 
obtained on transfer of graded numbers of normal spleen cells with or without 
addition of a constant number of KLH-primed splenic T  cells. Addition of 7.5  x 
10  ~ KLH-primed and nylon-purified (15)  cooperators results  in  a  greater than 
10-fold increased response at each dose of normal spleen tested. Thus in normal 
spleen, cooperators for the DNP-KLH response are limiting on transfer. 
The increase in response of a fixed number of normal spleen cells transferred as 
a  function of the number of carrier-primed T  cells added is shown in Fig.  1 b. 
There is about a  10-fold greater than additive increase in response with addition 
of  5  x  106  KLH-primed  splenic  T  cells.  This  increase  must  be  due  to  the 
expression of DNP-PFC  precursors  derived from the normal spleen,  since the 
response of 5 x  106 T cells transferred alone could have accounted for only 10% of 
the response of the mixture of normal spleen and T  cells. 
The  addition  of  5  x  106  cooperators  allows  maximal  expression  of  the 
DNP-PFC precursors in 5 x  106 normal spleen cells. When 1 ×  107 carrier-primed 
T  cells are  added  (in  another experiment), there is  no further increase in the 
number of PFC observed (26  x  103 PFC/spleen with 5  x  10  ~ T  cells and 29 x  103 
PFC/spleen  with  1  x  107  T  cells.)  In  experiments  which  follow,  7.5  x  106 
carrier-primed  splenic  T  cells  were  added  to  populations  to  be  tested  for 
precursor activity in order to assure an excess of cooperator activity. 
~DNP-MGG-Binding  Cells  in  Normal  Mouse  Spleen.  The  proportion  of 
FDNP-MGG-binding cells in normal spleen detectable by fluorescence micros- 
copy  increases  with  the  staining  concentration of  ~DNP-MGG  (Table  I).  It 
reaches  a  plateau  of about  2.5%  at  a  staining  concentration of ~DNP-MGG 
between 500 and 1,600 tLg/ml. 10 5  - 
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Fro.  1.  (a)  Adoptive primary  dose  response to  DNP-KLH.  Irradiated  BAB/14  mice  were 
injected with either normal BALB/cN spleen cells alone or in conjunction with 7.5 x  l0  s 7-day 
KLH-primed nylon  column-purified splenic T  cells  (obtained from  BALB/cN  spleen  and 
contained 92% T  cells and 4% Ig-bearing cells as assessed by immunofluorescence). Animals 
received 100 gg alum-precipitated DNP-KLH intraperitoneally on the day of transfer, boosted 
with 10 gg aqueous DNP-KLH intravenously on day 5, and sacrificed on day 12. Each point 
represents the geometric mean of the responses of four animals and one SE about the mean is 
indicated. (b) Dose response of carrier-primed T  cells. Irradiated BAB/14 mice were injected 
with  either  2.5-mo  KLH-primed  nylon  column-purified  splenic  T  cells  (obtained  from 
BALB/cN  spleen  and  contained  89%  T  cells  and  4%  Ig-bearing  cells  as  assessed  by 
immunofluorescence) alone or in combination with 5 x  10 e normal BALB/cN spleen cells. See 
legend Fig.  1 a  for immunization regime. Each point represents the geometric mean of the 
response of four animals and one SE about the mean is indicated. 
TABLE  I 
Effect of FDNP-MGG Concentration on the Number of Labeled 
Lymphocytes in Normal Mouse Spleen 
Staining concentration*  No. of lymphocytes~ 
of FDNP-MGG  counted ( × 10 ~)  Labeled lymphocytes 
ttg/rnl  % 
6  101  0.03 
18  51  0.1 
55  19  0.3 
167  15  1.6 
500  15  2.7 
1,600  15  2.3 
* Normal BALB/cN spleen cells were prepared and stained with F DNP-MGG as 
described in the Materials and Methods. 
Cell smears were first examined under white-light darkfield illumination and 
only  those cells with  intact plasma  membranes exhibiting speckled, ringed, 
or capped membrane-associated fluorescence were considered positive. 
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The  increased proportion of binding cells with the rDNP-MGG  concentration 
reflects  a  wide  range  of avidity  in  the  binding  population  as  well as  a  certain 
degree of nonspecificity. High avidity binding cells (i.e., those which stain at low 
~DNP-MGG  concentrations)  are  specific  for  DNP.  A  100-fold  molar  excess  of 
e-DNP-lysine  reduced  the  number  of  detectable  binding  cells  to  15%  of  the 
control  (see  Table  II).  However,  binding  by  low  avidity  cells  showed  less 
TABLE II 
Specific Inhibition of FDNP-MGG-Binding Cells 
Molarity of  Molarity of 
Staining  DNP$ on  e-DNP-lysine§  FDNP-MGG [I-  Inhibition of 
concentration*  7DNP-MGG  in staining mix-  labeled  binding of 
rDNP-MGG  ×  10 -e M  ture ×  10 _5 M  lymphocytes  FDNP-MGG 
~g/ml  %  % 
167  27  --  1.0  -- 
27  0.9  10 
270  0.8  20 
55  9  --  0.38  -- 
9  0.33  25 
90  0.20  50 
18  3  --  0.20  -- 
3  0.12  40 
30  0.08  60 
6  1  --  0.07  -- 
1  0.02  71 
10  0.01  86 
* Normal BALB/cN spleen cells were prepared and double  stained with ~DNP-MGG  and RKLH as 
described  in the Materials and Methods.  500 #g/ml of RKLH was included in all staining mixtures. 
The  percent  of RKLH-labeled  lymphocytes ranged  from  0.20 to  0.28% in  tubes  not  containing 
~-DNP-lysine.  None of the  concentrations of  e-DNP-lysine  used  in  inhibitions significantly de- 
creased  the  number  of ~KLH-binding lymphocytes.  The  percent  of RKLH-labeled  lymphocytes 
observed  in the presence  of from  1 to 27  ×  10-5 M  ~-DNP-lysine ranged  from 0.20 to 0.26%. 
$ The effective molarity of DNP present in varying concentrations of FDNP-MGG was calculated on 
the basis  of 23 mol of DNP/mol (150,000 daltons)  of MGG. 
§ Either a 10- or 100-fold molar excess of e-DNP-lysine  {based on the molarity of DNP present in the 
form of rDNP-MGG) was added to the staining mixtures for inhibition studies. 
II Rhodamine-labeled glutaraldehyde-fixed chicken erythrocytes (which fluoresce under both fluores- 
cein and rhodamine illumination conditions)  were added to the stained spleen  cells in a ratio of 
1:200  before  smears  were  prepared.  Slides were  scanned  for  FDNP-MGG-binding  cells and the 
proportion  of labeled lymphocytes calculated based on the number of chicken erythrocytes counted. 
The same procedure  was used to determine the proportion of SKLH-binding lymphocytes.  Between 
5,000 and 30,000 lymphocytes were scanned on each slide. 
specificity in that a  100-fold molar excess of e-DNP-lysine at the highest staining 
concentration reduced the number  of detectable binding cells only to 80% of the 
control.  Recent  experiments 4  indicate  that  a  major  component  of  this  non- 
specificity is due to binding of the MGG  moiety of the  ~DNP-MGG. 
4  Julius, M. H. Unpublished observations. 910  ISOLATION OF ANTIGEN-BINDING CELLS 
The Adoptive Primary Response o/Isolated  FDNP-MGG-Binding Cells.  2% 
of normal  BALB/cN  splenic  lymphocytes  bound  detectable  ~DNP-MGG  at  a 
high-staining concentration  (167 #g/ml). Isolation of these cells using the FACS 
yielded a  population  containing 91%  ~DNP-MGG-binding  cells and  a  ninefold 
depleted  population  containing  0.3%  binding  cells  (see  Table  III).  These 
populations  were  assayed for DNP-PFC  precursor activity in  adoptive transfer 
experiments  with carrier-primed T  cells. Transfer without carrier-primed T  cells 
resulted in low DNP-PFC  responses  (see Table III). 
To  test  for enrichment  of precursor  activity,  the  number  of isolated binding 
TABLE  III 
Adoptive Primary Response of Purified rDNP-MGG-Binding Cells 
% Fluorescent cells* in 
fractions  No. of cells transferred (× 106)$  Direct  Total 
anti-DNP §  anti-KLH I[ 
Unfrac-  ~DNP-  VDNP-  KLH-  Unfrac-  FDNP-  PDNP-  PFC/spleen  titer 
tionated  MGG  MGG  primed  tionated  MGG  MGG  (× l0 s)  (logs) 
(+)  (-)  T~  (+)  (-) 
2.0  91  0.3  --  5  --  --  6  (4-9)  2.0  ±  0 
7.5  --  --  --  6 (6-7)  3.4 ± 0.6 
--  --  0.1  --  1  (0.8-1)  3.5  ±  0.5 
--  --  --  5  1  (0.5-2)  4.0  ±  0 
7.5  5  --  --  59 (52-67)  8.5 :e 2.9 
7.5  --  0.1  --  27 (23-30)  4.0 ± 0 
7.5  --  --  5  28 (24-33)  8.5 ± 2.9 
* BALB/cN normal spleen cells were stained with FDNP-MGG at 167 #g/ml.  DNP-MGG-positive 
and -negative cells were isolated using the FACS as described in the Materials and Methods. 
Unfractionated, ~DNP-MGG (+), or FDNP-MGG (-) cell populations were transferred into 600 R 
irradiated BAB/14  mice intravenously. Animals received 100 ~g alum-precipitated DNP-KLH on 
day 0,  10 gg aqueous DNP-KLH on day 5, and were bled and sacrificed on day 12. 
§ Geometric mean of the responses of four animals. Numbers ih parentheses represent one SE about 
the mean. 
[[ Logs anti-KLH hemagglutination titer ±  SE. Each number represents the arithmetic mean of the 
titers of four animals. 
¶ KLH-primed T cells were isolated from 7-day primed BAB/14 spleens by nylon wool passage and 
contained 93% T cells and 1.4% Ig-bearing cells as assessed by immunofluorescent staining. 
cells transferred from the enriched fraction was adjusted to be roughly equivalent 
to the number  of binding cells found  in 5  ×  10 e unfractionated  spleen. Thus,  in 
this  experiment  1  ×  105  isolated binding cells (at 91%  purity)  were transferred 
since  the  unfractionated  population  contained  2%  binding  cells.  As  seen  by 
comparing lines 5 and 6 of Table III, 105 cells of the DNP  (÷) fraction gave rise to 
slightly fewer DNP-PFC  (actually half as  many  in this experiment)  as 50 times 
more  unfractionated  cells.  Thus,  the  precursor  activity in  the  antigen-binding 
cells is greatly enriched. 
To assess depletion of precursor activity, equal numbers  of the unfractionated 
and  the  DNP-negative  cells were transferred  along with T  cells. Comparison  of 
the last two lines of Table III shows no apparent  depletion. However (see below), 
there  is  a  striking  qualitative  difference  in  the  PFC  obtained  from  the  two 
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The enrichment for DNP-PFC precursors was specific in that it did not give a 
concomitant enrichment for anti-KLH precursors. The DNP (+) fraction gave a 
KLH response not above the background from KLH-primed B cells contaminat- 
ing the T  cells. Furthermore, the depleted fraction contained the same anti-KLH 
precursor activity as unfractionated spleen  (see Table III). 
Relationship Between the Avidity of ~DNP-MGG Binding DNP-PFC Precur- 
sor  Cells  and  the  DNP-PFC Resulting  on  Transfer  of Purified Binding  Cells. 
There  is  a  striking  qualitative  difference  in  the  DNP-PFC  obtained  from the 
depleted  fraction and  the  DNP-PFC obtained  from either the  isolated binding 
cells or unfractionated spleen. The avidities of the DNP-PFC in the recipients of 
the depleted fraction are about 300-fold lower. 
The  avidities  of DNP-PFC  were  determined  by sensitivity  to  inhibition  by 
either e-DNP-lysine or DNP-MGG. The data in Fig. 2 a show that while only 45% 
of the DNP-PFC in recipients of cells from the depleted fraction are inhibited at 
the  highest  concentration  of  e-DNP-lysine  (10-' M),  the  same  concentration 
inhibited  90%  of  the  DNP-PFC  in  recipients  of  unfractionated  spleen.  By 
interpolation,  45%  of the DNP-PFC in recipients of unfractionated spleen were 
inhibited  at  about  3  ×  10 -7 M  e-DNP-lysine, a  factor of 300 higher.  All of the 
DNP-PFC in the  recipients  of cells from the depleted  fraction are inhibited by 
DNP~8-MGG indicating that even the lowest avidity PFC  are specific for DNP. 
(The  multivalency of DNP on DNP-MGG makes  it  a  more  efficient  inhibitor 
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FIG. 2.  (a) Inhibition profiles of DNP-PFC by ~-DNP lysine. Cells are from spleens of mice 
receiving carrier-primed T cells in addition to either FACS-purified splenic ~DNP-MGG (+) 
binding cells {stained with FDNP-MGG at  167 ~g/ml), the corresponding depleted fraction 
(-),  or  whole spleen cells. Details of adoptive  transfer  in  the  Materials  and  Methods. 
e-DNP-lysine was included in the plaquing chambers. Each point represents the geometric 
mean of the percent inhibition of the PFC responses of four animals compared to the geometric 
mean of four animals for each control group. One SE about the mean is indicated. The mean 
number of uninhibited  PFC/spleen in these groups are given in lines 5-7 of Table III. In 
addition, the effect of the various concentrations of ~-DNP-lysine on a day 4 primary response 
to SRBC is shown. (b) Inhibition profiles of anti-DNP PFC by DNP-MGG. See legend of Fig. 
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than e-DNP-lysine.) Neither e-DNP-lysine nor DNP23-MGG inhibit anti-SRBC- 
PFC (see Fig. 2). 
Reduction  in  the  avidity  of the  DNP-PFC  in  recipients  of cells  from  the 
fraction  depleted of nearly all  cells which bind rDNP-MGG at a  high-staining 
concentration  suggests  that  low avidity  DNP-PFC  precursors  give  rise  to  low 
avidity  DNP-PFC.  This  is  consistent  with  the  observation that  the  avidity of 
DNP-PFC in recipients of cells from the enriched fraction appear to be slightly 
higher than  the DNP-PFC in recipients of unfractionated spleen (see Fig. 2 a). 
The  high  FDNP-MGG  concentration  used  here  stained  nearly  all  the  ~DNP- 
MGG-binding cells in the unfractionated spleen (see Tables I and II), therefore 
only the very low avidity precursors are expected to be absent from the enriched 
fraction. Thus, the higher avidity of the DNP-PFC in the recipients of cells from 
the enriched fraction reflects this absence. 
Isolation of High Avidity FDNP-MGG-Binding Cells and Assessment of Their 
Precursor Activity.  To  determine  whether  high  avidity  FDNP-MGG-binding 
cells  contained  the  precursors  of high  avidity  PFC,  normal  BALB/cN  splenic 
lymphocytes were stained  at  a  low concentration  of rDNP-MGG  (10 #g/ml)  to 
allow isolation of the highest avidity lymphocytes. 
At this staining concentration,  0.2% of the lymphocytes bound detectable (by 
fluorescence  microscopy)  FDNP-MGG  and  the  FACS-enriched  fraction  con- 
tained  85%  rDNP-MGG-binding  cells  (see  Table  IV).  The  depleted  fraction 
contained less than 0.03% fluorescent binding cells. It also should contain those 
low avidity binding lymphocytes which are detected at higher VDNP-MGG-stain- 
ing concentrations  (compare Table I). 
The avidity of the DNP-PFC in recipients of the stained (high binding avidity) 
cells  are  100-fold  higher  than  the  avidity  of the  DNP-PFC  derived  from  the 
depleted fraction  (Fig.  3).  The  lines  in  this  figure  show that  while 75% of the 
DNP-PFC  obtained  from  the  enriched  fraction  are  inhibited  by  10  6  M 
e-DNP-lysine, 10 _4 M  e-DNP-lysine is required to inhibit the same proportion of 
DNP-PFC obtained from the depleted fraction. Thus, enrichment of high avidity 
FDNP-MGG-binding cells gives concomitant enrichment  for high avidity DNP- 
PFC precursors. 
In  the  recipients  of  cells  from  the  depleted  fraction,  the  avidity  of  the 
DNP-PFC were 10-fold lower than the DNP-PFC in recipients of unfractionated 
spleen. This contrasts  with the last experiment  (see Fig. 2) where the depleted 
fraction  obtained  from  a  population  stained  with  a  high  concentration  of 
~DNP-MGG  gave  rise  to  DNP-PFC  of  300-fold  lower  avidity  compared  to 
unfractionated spleen. Thus, when the majority of the high avidity binding cells 
are  removed,  the  depleted  fraction  contains  the  medium  and  low  avidity 
DNP-PFC  precursors  (as  well  as  any  contaminating  high  avidity  precursors 
missed  in  the  separation)  which  can  be  removed  by  increasing  the  staining 
concentration. This suggests that over a wide range of avidities there is a direct 
correlation  between the avidity of the ~DNP-MGG-binding precursor cells and 
the avidity of the DNP-PFC they produce. 
Several additional  controls relevant to the entire study were included in this 
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TABLE  IV 
Adoptive Primary Response of Purified High Avidity VDNP-MGG-Binding Cells 
% Fluorescent cells* in 
fractions 
No. of cells transferred (× 106)$ 
VDNP-  FDNP-  KLH-  VDNP-  VDNP- 
Unfrac-  Unfrac- 
tionated  MGG  MGG  primed  tionated  MGG  MGG 
(+)  (-)  rl~  (+)  (--) 
Direct  Total 
anti-DNP §  anti-KLH ]1 
PFC/spleen  titer 
( ×  10 a)  (log~) 
0.2  84  <0.03  --  5  --  --  9  (5-16)  3.0  ±  0.6 
7.5  --  --  --  2 {1-2)  4.7 ±  0.8 
--  --  0.05  --  0.7  (0.5-1)  2.5  ±  0.5 
--  --  --  5  8  (5-16)  2.0  ±  0 
7,5  5  --  --  30 (27-34)  12 ±  4.1 
7.5  0.05  --  --  5 (4-6)  2.7  ±  1.3 
7.5  --  0.05  --  20 (17-23)  3.3  ± 0.7 
7.5  --  0.05  --  3 (2-3)**  2 ±  0.5 
7.5  --  --  5  20 (17-22)  10 ±  1.8 
* BALB/cN normal spleen cells were stained with  FDNP-MGG at  10 #g/ml.  VDNP-MGG-positive 
and -negative cells were isolated using the FACS as described in the Materials and Methods. 
Unfractionated,  VDNP-MGG (+), or VDNP-MGG (-)  cell populations were transferred into 600 R 
irradiated  BAB/14  mice  intravenously.  All  but  one  group  of  animals  received  100  ~g  alum- 
precipitated DNP-KLH on day 0, 10 ~g aqueous DNP-KLH on day 5, and were bled and sacrificed 
on day 12. 
§ Geometric mean of the responses of four animals. Numbers in parentheses represent one SE about 
the mean. 
II Log~ anti-KLH hemagglutination titer ±  SE. Each number represents the arithmetic mean of the 
(log2)  titers of four animals. 
¶ KLH-primed T  cells were isolated from BAB/14 spleens by nylon wool passage and contained 95% T 
cells and 0.7%  Ig-bearing cells as assessed by immunofluorescent staining. 
** For this group of animals KLH was substituted for DNP-KLH. 
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Fro. 3.  Same as Fig.  2 a  except cells were separated after staining at  10 #g/ml FDNP/MGG. 
The mean number of uninhibited PFC per spleen in these groups are given in lines 5, 7, and 9 of 
Table IV. 914  ISOLATION  OF ANTIGEN-BINDING  CELLS 
precursor  activity,  while  the  depleted  fraction  contained  the  same  anti-KLH 
precursor  activity  as  the  unfractionated  spleen  (see  Table  IV).  The  hapten 
specificity  of  the  isolated  binding  cells  was  further  demonstrated  since  the 
DNP-PFC response obtained when recipients of isolated cells are challenged with 
KLH  was  15%  of  the  response  obtained  when  DNP-KLH  was  used  as  the 
immunogen.  In  addition,  transfer  of  5  ×  104  unfractionated  spleen  which 
contained  0.2%  binding  cells  gave rise to only 5  x  103 DNP-PFC  emphasizing 
that enrichment for ~DNP-MGG-binding cells is specific for DNP-PFC precursor 
activity  (see Table IV). To complete the  demonstration  that the  avidity of the 
antigen-binding  precursor  cell  is  directly  related  to  the  avidity of the  progeny 
PFC,  low avidity ~DNP-MGG-binding  cells were isolated directly and shown to 
be the  precursors of low avidity DNP-PFC. 
Isolation of Medium  and Low Avidity DNP-PFC Precursors.  In this  experi- 
ment,  low  avidity  binding  cells  were  differentially  labeled  by  staining  with 
FDNP-MGG in the presence of e-DNP-lysine which blocked staining of the high 
avidity binding cells. 
When  normal BALB/cN spleen cells were stained  with 55 #g/ml ~DNP-MGG 
in  the  presence  of a  100-fold  molar  excess  (calculated  from DNP  residues)  of 
e-DNP-lysine,  0.8% of the lymphocytes bound  detectable  ~DNP-MGG. Passage 
of this population through the FACS yielded an enriched population containing 
90%  ~DNP-MGG-binding cells and a depleted fraction containing 0.03% binding 
cells  (see  Table  V).  The  isolated  binding  cells  were  enriched  100-fold  for 
DNP-PFC  precursor  activity,  while  the  depleted  fraction  was  depleted  twofold 
for DNP-PFC  precursor activity (see Table V). 
TABLE  V 
Adopti~'e Primao' Response  of Purified Medium and Low Avidity 
FDNP-MGG-Binding Cells 
% Fluorescent cells*  No. of cells transferred ( x  10e)$ 
Direct anti-DNP§ 
FDNP-  ~DNP-  KLH-  ~DNP-  FDNP- 
Unfrac-  MGG  MGG  Primed  Unfrac-  MGG  MGG  PFC/spleen (×  103) 
tionated  tionated 
(+)  (  )  TI[  (+)  (  ) 
0.8  90  0.03  --  5  --  --  6  (5-8) 
7.5  --  --  --  4 (2-7) 
--  --  o.05  --  0.3 (0.2-0.5) 
--  --  --  5  3  (3-4) 
7.5  5  --  --  47 (41-54) 
7.5  --  0.05  --  40 (38-43) 
7.5  --  --  5  29 (26-31) 
* BALB/cN normal spleen cells were stained with ~DNP-MGG at 55 ttg/ml in the presence of 8.7  × 
10  4 M  ~-DNP-lysine.  ~DNP-MGG-positive and  -negative cells were  isolated using the FACS  as 
described in the Materials and Methods. 
$ Unfractionated,  ~DNP-MGG (+)  or ~DNP-MGG (-)  cell  populations were transferred into 600 R 
irradiated  BAB/14 mice intravenously. All animals received 100 ttg alum-precipitated  DNP-KLH 
on day 0,  10 ~g aqueous DNP-KLH  on day 5, and were sacrificed on day 12. 
§ Geometric mean of the responses of four animals. Numbers in parentheses represent one SE about 
the mean. 
II KLH-primed T  cells were isolated from BAB/14 spleens by nylon wool passage and contained 93% T 
cells and 1% Ig-bearing cells as assessed by immunofluorescent staining. 915 
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The data  in Fig.  4 show that the  avidity of the DNP-PFC obtained from the 
isolated medium and low avidity binding cells are 100-fold lower than the avidity 
of the  DNP-PFC  obtained  from  the  depleted  fraction.  While  10 -~  M  e-DNP- 
lysine inhibited 60% of the DNP-PFC obtained from the enriched fraction, only 
10 -7 M  was required to inhibit the same proportion of DNP-PFC obtained from 
the depleted fraction. 
The  avidity  of  the  DNP-PFC  obtained  from  enriched  fraction  in  this 
experiment were slightly lower than the avidity of the DNP-PFC obtained from 
the  unfractionated spleen,  which suggests that under these staining conditions, 
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Fro. 4.  Same as Figure 2 a except cells were separated after staining at 55 #g/ml FDNP-MGG 
in the presence of 8.7  ×  10  4 M e-DNP-lysine. The mean number of uninhibited PFC per 
spleen in these groups are given in lines 5-7 of Table V. 
the medium and low avidity DNP-PFC precursors are stained while staining of 
the highest avidity precursors was blocked by E-DNP-lysine. 
Discussion 
The  concept of clonal  selection  (28) rests  on two basic  assumptions:  (a)  precursors of 
antibody-forming  cells  are  antigen-binding  cells,  and  (b)  antigen  receptors  on  the 
precursors have the same specificity and affinity as the antibody secreted by the progeny 
plasma  cells.  Although  much  of  the  data  accumulated  in  cellular  immunology  is 
consistent with the predictions of clonal theory, there have been few studies which provide 
direct evidence to validate these basic assumptions. 
To demonstrate that the precursors of antibody-forming cells are antigen-binding cells, 
Wigzell  and M~ikel~i (29) passed suspensions of primed or unprimed spleen cells through 
antigen-coated columns. With this method, they specifically depleted the precursors from 
the  column effluent population but were  unable  to recover cells  enriched for precursor 
activity from the  column.  Ada  and  Byrt  (30) also  showed that  specific  precursors are 
depleted  from spleen  cell  populations when  allowed to bind highly radioactive antigen 
("suicide" experiments).  These experiments gave strong support for the role of antigen- 916  ISOLATION  OF  ANTIGEN-BINDING  CELLS 
binding cells as precursors but the question still remained open because of the inability to 
isolate these cells and directly test their function. 
The  development  of  the  FACS  has  now  allowed  the  isolation  of  functional 
antigen-binding  cells. In a  previous publication,  we showed that the KLH-bind- 
ing cells isolated from KLH-primed spleen  contained  all the  anti-KLH precur- 
sors  present  in  intact  spleen  (5).  We  therefore  firmly  established  that  the 
precursors of antibody-forming cells in primed spleen are antigen-binding cells. 
In  this  work  we  have  extended  this  conclusion  to  antigen-binding  cells  in 
unprimed  animals.  We  have  shown  that  isolated  DNP-binding  cells  are  the 
precursors of anti-DNP  antibody-secreting cells. Moreover,  we have shown that 
the  avidity of the  antibody produced by the antibody-secreting cell reflects the 
avidity of the receptor on the  antigen-binding  precursor cell. 
In the experiments reported here, high avidity DNP-binding cells gave rise to 
predominantly high avidity DNP-PFC. Isolation and transfer of medium and low 
avidity  binding  cells  gave rise  to  medium  and  low avidity DNP-PFC.  In  both 
cases, transfer of the complementary unstained populations (i.e., the "depleted" 
fractions)  gave rise to DNP-PFC  with  avidities  in  the  range expected for those 
precursors intentionally  left unstained. 
The  determination  of  DNP-PFC  avidities  is  based  on  their  inhibition  by 
e-DNP-lysine as described  by Andersson  (3)  in  1970.  Hapten inhibition of PFC 
has  been  shown  to  be  a  valid  measure  of antibody  avidity  in  other  systems. 
Yamada  et  al.  (31)  have shown that  mouse  myeloma (MOPC-315)  cells,  which 
secrete  homogeneous  IgA molecules with  a  uniform binding  constant  for DNP, 
form DNP-specific  plaques.  All of the  DNP-PFC  were sharply  inhibited  over a 
very narrow concentration range of e-DNP-lysine included in the plaquing assay. 
50% of the  DNP-PFC  were inhibited  by a  concentration  of e-DNP-lysine which 
closely  approximated  the  reciprocal  of  the  binding  constant  of the  myeloma 
protein. 
Although these results indicate the possibility of avidity, or in fact affinity, measurements 
at  the  cellular  level,  certain  restrictions  to  the  use  of hapten  inhibition  for  avidity 
determinations merit consideration here. First, it may be used (uncorrected) to determine 
avidity only when there is a relatively constant rate of antibody secretion among PFC in a 
given experiment, i.e., when plaque size is relatively constant. Since the avidity measured 
by this method is a weighted average between the local antibody concentration and the 
true avidity of the antibody secreted, large differences in rates of antibody secretion will 
cause  apparent  avidity  differences  between  two  PFC  secreting  identical  antibody 
molecules. Such  differences have been shown experimentally with PFC from the B-cell 
clone  E9  which  secretes  a  homogeneous  immunoglobulin  specific for DNP  when  large 
variation in uninhibited plaque size was observed (~ 10-fold)  (32). In our experiments, the 
variation in uninhibited plaque size was small (~twotbld). Therefore, it is likely that the 
major parameter measured in these experiments is relative avidity of anti-DNP antibody 
rather than the amount secreted per DNP-PFC. 
Secondly,  if  IgG  and  IgM  PFC  are  present  in  the  same  experiment,  the  hapten 
concentrations  giving  equivalent  inhibitions  might  well  be  quite  different  due  to  the 
differing valencies of the  different  antibodies.  In these  experiments,  as will  be further 
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Thirdly, comparison of avidities for PFC between experiments  may be made only when 
the extent of hapten conjugation to indicator erythrocytes is kept constant. Pasanen and 
M~ikel~i (33) have shown that the ability to inhibit PFC with free hapten decreases as the 
extent of hapten conjugation to indicator cells increases. Therefore, while comparison of 
PFC avidity is valid within a given experiment,  it must be considered a relative  value 
when comparing experiments unless the hapten conjugation is strictly controlled between 
experiments. This restriction  applies to the data we have reported since each experiment 
was performed with newly conjugated erythrocytes which may have varied somewhat with 
respect to the extent of hapten conjugation. Therefore, the data is discussed in terms of 
the avidities of DNP-PFC from the unfractionated populations  in each experiment. 
Despite this reservation, there is  at least a  rough correlation between average 
avidities measured in different experiments. The average avidities of DNP-PFC 
obtained from adoptive secondary transfers (i.e., transfer of DNP-KLH-primed 
spleen)  measured  in  other  experiments  are  100-fold  higher than the  average 
avidities of the DNP-PFC which we find here in an adoptive primary transfer  s 
(high avidity PFC obtained in adoptive secondary transfers are predominantly 
due to IgG antibody, whereas the PFC in these adoptive primary transfers are 
virtually all due to IgM antibody). This difference in avidities is consistent with 
higher affinity antibody found in a secondary response (1) and suggests that the 
hapten  inhibition method may be  used for comparisons between experiments 
when there are large avidity differences. 
Very few, if any, IgG DNP-PFC are found in the adoptive primary recipients in 
the  experiments  reported  here,  although  supplementation  of  an  unprimed 
precursor  population  with  carrier-primed  cooperator  cells  has  been  shown to 
favor the production of IgG PFC in other systems (34,  35).  It may be that the 
numbers  of IgG  DNP-PFC  would  have  been  larger  had  there  been  a  larger 
interval  between  antigen  boost  and  day  of  assay  for  PFC.  Using  a  similar 
adoptive primary transfer system, the peak IgG anti-DNP serum titer occurred at 
day 30 after transfer, while at day 12 the anti-DNP titer was due completely to 
IgM antibody2 
The  absolute  primed  T-cell  dependence  of  this  adoptive  primary  DNP 
response both with unfractionated spleen cells and the isolated antigen-binding 
cells is remarkable in view of the wholly IgM response (at 12 days). This absolute 
dependence is manifest even when only the highest avidity DNP precursors are 
used  with  all  the  remaining normal  spleen  cells  present,  except  for low  and 
medium  avidity  DNP-binding  cells  hence  precursors.  This  may  provide  an 
exquisitely sensitive system for assay of active T  cells or T-cell substitutes. The 
recipients are boosted with rather large amounts of DNP-KLH for the presumed 
relatively few high  avidity precursors.  Any explanation of T-cell  dependence 
invoking aid to better antigen binding by precursors would be least applicable, 
one would expect, to these high avidity cells. It will be interesting to see whether 
continued  stimulation  of  these  precursors  will  lead  to  production  of  IgG 
DNP-PFC  and  with  higher  avidities  or  whether  some  suppression  of these 
indirect PFC is occurring. 
Metzler, C. M. Unpublished observation. 
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Summary 
Cells binding DNP groups conjugated to fluoresceinated mouse gamma globulin 
(FDNP-MGG) were isolated from spleens of unprimed mice using a fluorescence- 
activated cell sorter (FACS). The isolated cells were specifically enriched at least 
100-fold  for  anti-DNP  precursor  activity  in  an  adoptive  transfer  assay  as 
compared  to  unfractionated  spleen.  The  fraction  depleted  of  binding  cells, 
although  depleted of anti-DNP precursor activity, responded as well as unfrac- 
tionated  spleen  when  assayed  for  anticarrier  (keyhole  limpet  hemocyanin 
[KLH]) precursor activity. 
High  avidity  binding  cells  were stained  using  low concentrations  of ~DNP- 
MGG. Medium and low avidity binding cells were stained using high concentra- 
tions  of FDNP-MGG  in  the  presence  of free hapten  which  selectively blocked 
staining of the high avidity binding cells. Cells were supplemented with an excess 
of  carrier-primed  (KLH),  nylon-purified  splenic  T  cells  and  transferred  to 
irradiated  recipients.  DNP-KLH  was  given  at  transfer  and  5  days later.  The 
anti-DNP  plaque-forming  cell  (DNP-PFC)  response  and  the  avidities  of the 
DNP-PFC  in  the  irradiated  recipients  were measured  by hapten  inhibition  of 
direct  PFC  plaque  formation  12  days  after  transfer.  At  this  time,  very  few 
indirect PFC were found. 
There was a positive correlation between the avidity of the DNP-binding cells 
and the avidity of the anti-DNP antibody secreted by their progeny. High avidity 
DNP-binding  cells  gave  rise  to  predominantly  high  avidity  anti-DNP-PFC. 
Medium  and  low  avidity  binding  cells  gave  rise  to  medium  and  low avidity 
DNP-PFC. 
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